Outcome measures
Individual participants in all three groups were assessed on a variety of outcomes (described below) immediately after the 16-week intervention (T1), and at 6 months (T2), and 12 months (T3) post-intervention. The outcomes were compared with the baseline assessment (T0). The baseline assessment (T0) was conducted beginning in March 2018, while the 12-month post-intervention (T3) ended in December 2020.